First Time Loading...
A

Akoya Biosciences Inc
NASDAQ:AKYA

Watchlist Manager
Akoya Biosciences Inc
NASDAQ:AKYA
Watchlist
Price: 4.04 USD 1.25% Market Closed
Updated: May 5, 2024

Akoya Biosciences Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Akoya Biosciences Inc
Operating Income Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
A
Akoya Biosciences Inc
NASDAQ:AKYA
Operating Income
-$57.7m
CAGR 3-Years
-69%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Operating Income
$7.3B
CAGR 3-Years
-2%
CAGR 5-Years
14%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Operating Income
$9.5B
CAGR 3-Years
20%
CAGR 5-Years
26%
CAGR 10-Years
12%
Mettler-Toledo International Inc
NYSE:MTD
Operating Income
$1.1B
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Operating Income
$1.3B
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
16%
IQVIA Holdings Inc
NYSE:IQV
Operating Income
$2.1B
CAGR 3-Years
38%
CAGR 5-Years
21%
CAGR 10-Years
16%

See Also

What is Akoya Biosciences Inc's Operating Income?
Operating Income
-57.7m USD

Based on the financial report for Dec 31, 2023, Akoya Biosciences Inc's Operating Income amounts to -57.7m USD.

What is Akoya Biosciences Inc's Operating Income growth rate?
Operating Income CAGR 3Y
-69%

Over the last year, the Operating Income growth was 13%. The average annual Operating Income growth rates for Akoya Biosciences Inc have been -69% over the past three years .